Case Series

Feasibility and Safety of Sodium Glucose Cotransporter-2 Inhibitors in Adults with Heart Failure after the Fontan Procedure

Table 1

Summary of baseline characteristics in five patients after Fontan procedure who were treated with a SGLT-2 inhibitor.

CaseSexAgePrimary diagnosisPrior proceduresAge at Fontan (years)
Type of Fontan
ComorbiditiesBMI (kg/m2)CI (L.min-1.m-2)CVP (mmHg)EF (%)Valve regurg.Peak VO2 (%)Times of unexpected hospitalization and reasons

1Male45AVSD, MGA, PA, IVCD, left isomerismAP shunt, TCPS, PMI22
ECC
Heart failure
PAf
Chylothorax/ascites
FALD
21.04.87
High CI
2053Mod AR
Mod AVVR
ā€”19 (0.82/year)
Heart failure
PAf
2Male36AVSD, MGA, PS, right isomerismAP shunt13
ECC
Heart failure
Hypertension
Obesity
Diabetes
CKD
CNS hemorrhage
31.32.55
Low CI
1153Mild AVVR5810 (0.45/year)
Heart failure
Thrombosis
Infection
3Male35DORV, hypoplastic LVPAB, BCPS11
ECC
Heart failure
Obesity
DM
CKD
FALD
37.95.02
High CI
1854Mild AVVR522 (0.08/year)
Heart failure
4Male21HLHSNorwood, BCPS1
ECC
Heart failure
PLE
PB
16.55.09
High CI
1153Mod AVVRā€”29 (1.52/year)
Heart failure
PLE/PB
5Male24AVSD, MGA, PA, right isomerismAP shunt, BCPS2
ECC
DM
CKD
24.02.32
Low CI
1241Mod AVVR711 (0.04/year)
Heart failure

Times of admission means unexpected admission due to not scheduled examination or treatment but cardiovascular symptoms. AP shunt: aortopulmonary shunt; AVSD: atrioventricular septal defect; BMI: body mass index; CI: cardiac index; CKD: chronic kidney disease; CNS: central nervous system; CVP: central venous pressure; DM: diabetes mellitus; DORV: double outlet right ventricle; ECC: extracardiac conduit; EF: ejection fraction; FALD: Fontan-associated liver disease; HLHS: hypoplastic left ventricle; IVCD: inferior vena cava defect; LV: left ventricle; MGA: malposition of the great arteries; PA: pulmonary atresia; PAB: pulmonary arterial banding; PAf: paroxysmal atrial fibrillation; PB: plastic bronchitis; PLE: protein-losing enteropathy; PMI: pacemaker implantation; PS: pulmonary stenosis; TCPS: total cavopulmonary shunt; Valve regurg.: valve regurgitation.